Alkermes (ALKS) EBT (2010 - 2026)

Alkermes (ALKS) has 17 years of EBT data on file, last reported at -$61.9 million in Q1 2026.

• EBT for Q1 2026 came in at -$61.9 million, down 342.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $204.0 million (down 51.69% YoY), and the FY2025 annual result was $291.4 million, down 34.32% from the prior year.
• EBT eased to -$61.9 million in Q1 2026 per ALKS's latest filing, from $60.4 million in the prior quarter.
• Over five years, EBT peaked at $281.8 million in Q2 2023 and troughed at -$67.4 million in Q3 2022.
• A 5-year average of $62.6 million and a median of $60.4 million in 2025 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2023: EBT slumped 687.98% in 2022, then jumped 947.61% in 2023.
• A 5-year view of EBT shows it stood at $114.5 million in 2022, then tumbled by 49.06% to $58.3 million in 2023, then surged by 191.32% to $169.9 million in 2024, then tumbled by 64.46% to $60.4 million in 2025, then sank by 202.57% to -$61.9 million in 2026.
• Business Quant data shows ALKS's EBT at -$61.9 million in Q1 2026, $60.4 million in Q4 2025, and $100.7 million in Q3 2025.